Although most dietary DNMT inhibitors have been studied in cancer models, there is growing interest in their ability to counteract age-related DNA hypermethylation at specific CpG sites, potentially restoring a more youthful epigenetic profile without inducing harmful global hypomethylation. Here, DNMT1 is linked to cancer.